Pharmacological profile, clinical efficacy, and safety of Follitropin Delta produced by recombinant DNA technology in a human cell line (REKOVELLE<sup>®</sup> PEN for S.C. Injection 12 μg, 36 μg, 72 μg)-Reference-Cited by-同舟云学术

Pharmacological profile, clinical efficacy, and safety of Follitropin Delta produced by recombinant DNA technology in a human cell line (REKOVELLE^® PEN for S.C. Injection 12 μg, 36 μg, 72 μg)

Published:2022 Issue:1 Volume:157 Page:76-84
ISSN:0015-5691
Container-title:Folia Pharmacologica Japonica
language:en
Short-container-title:Folia Pharmacol. Jpn.

Author:

Abe Yoshiharu¹,Ozeki Yasushi¹

Affiliation:

1. Medical Affairs, Ferring Pharmaceuticals Co., Ltd.

Publisher

Japanese Pharmacological Society

Subject

Pharmacology

Link

https://www.jstage.jst.go.jp/article/fpj/157/1/157_21079/_pdf

Reference33 articles.

1. 1) World Health Organization and The World Bank. World report on disability, 2011. Available from: https://www.who.int/disabilities/world_report/2011/report/en/. Accessed 20 February 2020.

2. 2) World Health Organization. Infertility disability prevalence, 2004. Available from: https://www.who.int/reproductivehealth/topics/infertility/infertility_DIS_table.pdf?ua=1. Accessed 20 February 2020.

3. 3) National Institute of Population and Social Security Research. The 15th Japanese National Fertility Survey. 31 March 2017. Available from: http://www.ipss.go.jp/ps-doukou/e/doukou15/Nfs15_points_eng.pdf. Accessed 20 February 2020.

4. 4) 日本産科婦人科学会「体外受精・胚移植」に関する見解 2018年7月13日.

5. 5) Ishihara O, et al. Reprod Med Biol. 2019;19:3-12.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of biosynthetic human insulin and its analogues for diabetes management;Advances in Protein Chemistry and Structural Biology;2024

2. Descriptive analysis of Rekovelle® “real-world” experience;Journal of IVF-Worldwide;2023-09-05